“the team are currently refining the grown of the composite skin of the dermis and epidermis, making it more reliable and effective. Their aim is to start clinical trials within approximately 18 months”
So that would be by the end of calendar 2023 or beginning of 2024. Excellent news.
PNV Media Thread, page-2444
-
- There are more pages in this discussion • 775 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.67 |
Change
0.070(2.69%) |
Mkt cap ! $1.842B | |||
| Open | High | Low | Value | Volume |
| $2.63 | $2.76 | $2.62 | $10.48M | 3.925M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4520 | $2.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.67 | 20332 | 5 |
View Market Depth
| Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
| PNV (ASX) Chart |